A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma by J. Kaczmar, K. Papadopoulos, G. Ansstas, A. Birnbaum, J. Mehnert, O. Hamid, B. Hughes, G. Rabinowits, A. Wei, M. Yushak, J. Mani, F. Fang, J. Wang, G. Kroog, M. Salvati, I. Lowy, M. Fury, N.J. Lakhani

Get full text